These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27818694)

  • 1. High-Throughput Analysis of the T Cell Receptor Beta Chain Repertoire in PBMCs from Chronic Hepatitis B Patients with HBeAg Seroconversion.
    Qu Y; Huang Y; Liu D; Huang Y; Zhang Z; Mi Z; An X; Tong Y; Lu J
    Can J Infect Dis Med Microbiol; 2016; 2016():8594107. PubMed ID: 27818694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct T-cell receptor profiles associated with hepatitis B e antigen seroconversion during entecavir treatment.
    Lian YF; Xu Y; Gu YR; Bi YH; Liao CH; Zhao MX; Liao XL; Wang ZH; Wu HK; Huang YH
    Liver Int; 2020 Nov; 40(11):2672-2684. PubMed ID: 32564486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of serum ALT and T-cell receptor beta variable chain for HBeAg seroconversion in chronic hepatitis B patients during tenofovir treatment.
    Yang J; Yan D; Guo R; Chen J; Li Y; Fan J; Fu X; Yao X; Diao H; Li L
    Medicine (Baltimore); 2017 Mar; 96(10):e6242. PubMed ID: 28272219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotyping of immune-related loci associated with delayed HBeAg seroconversion in immune-active chronic hepatitis B patients.
    Liu WC; Wu IC; Chiu YC; Tseng KC; Chen CY; Chiu HC; Cheng PN; Chang TT
    Antiviral Res; 2020 Apr; 176():104719. PubMed ID: 32004619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tfh cell-mediated humoral immune response and HBsAg level can predict HBeAg seroconversion in chronic hepatitis B patients receiving peginterferon-α therapy.
    Zhang L; Zhang M; Li H; Chen Z; Luo A; Liu B; Chen M; Peng M; Ren H; Hu P
    Mol Immunol; 2016 May; 73():37-45. PubMed ID: 27037894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the expressed porcine Vbeta and Jbeta repertoire of thymocytes and peripheral T cells.
    Butler JE; Wertz N; Sun J; Sacco RE
    Immunology; 2005 Feb; 114(2):184-93. PubMed ID: 15667563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the distribution of CD8+ memory T cell subsets and IFN-γ level during the spontaneous clearance of hepatitis B virus in patients with chronic hepatitis B virus infection.
    Ma XJ; Chen XF; Chen WL; Chen R; Huang J; Luo XD; Liao JY; Chen XP
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4675-4679. PubMed ID: 29131246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the TCR β Chain Repertoire in Peripheral Blood from Hepatitis B Vaccine Responders and Non-Responders.
    Yang J; Li Y; Ye J; Wang J; Lu H; Yao X
    J Inflamm Res; 2022; 15():939-951. PubMed ID: 35210805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restricted TcR β chain CDR3 clonotype is associated with resolved acute hepatitis B subjects.
    Xiao D; Wang J; Chen Z; Jin X; Xie Y; Yan D; Yang J
    BMC Infect Dis; 2021 Jan; 21(1):111. PubMed ID: 33485302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.
    Yang HC; Chen CL; Shen YC; Peng CY; Liu CJ; Tseng TC; Su TH; Chuang WL; Yu ML; Dai CY; Liu CH; Chen PJ; Chen DS; Kao JH
    Hepatology; 2013 Mar; 57(3):934-43. PubMed ID: 23112104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the complementarity determining regions β-chain genomic rearrangement using high-throughput sequencing in periphery cytotoxic T lymphocytes of patients with chronic hepatitis B.
    Huang Y; Ma H; Wei S; Luo G; Sun R; Fan Z; Wu L; Yang W; Fu L; Wang J; Han D; Lu J
    Mol Med Rep; 2016 Jul; 14(1):762-8. PubMed ID: 27221081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL10 and its receptor in patients with chronic hepatitis B and their ability to predict HBeAg seroconversion during antiviral treatment with TDF.
    Yang J; Xu S; Cheng J; Yin X; Yan D; Li X
    J Med Virol; 2024 Mar; 96(3):e29516. PubMed ID: 38469895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Programmed death-1 (PD-1) and PD-L1 expression during antiviral treatment of chronic hepatitis B].
    Xie DY; Lin BL; Chen FJ; Deng H; Chong YT; Zhang XH; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):646-50. PubMed ID: 20943073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic Perturbations of CD4 and CD8 T Cell Receptor Repertoires in Chronic Hepatitis B Patients upon Oral Antiviral Therapy.
    Xu Y; Liu Y; Zhao M; Chen Y; Xie C; Gong M; Deng H; Li X; Sun J; Hou J; Wu H; Wang Z
    Front Immunol; 2017; 8():1142. PubMed ID: 28959264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT4 genetic polymorphism significantly affected HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients receiving Peginterferon-α therapy: A prospective cohort study in China.
    Qi X; Li F; Zhang Y; Zhu H; Yang F; Li X; Jiang X; Chen L; Huang Y; Zhang J
    J Med Virol; 2022 Sep; 94(9):4449-4458. PubMed ID: 35610746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency and skewed T-cell receptor beta-chain variable patterns of peripheral CD4(+)CD25(+) regulatory T-cells are associated with hepatitis B e antigen seroconversion of chronic hepatitis B patients during antiviral treatment.
    Yang J; Sheng G; Xiao D; Shi H; Wu W; Lu H; Cao H; Li L
    Cell Mol Immunol; 2016 Sep; 13(5):678-87. PubMed ID: 26899927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.
    Bayliss J; Yuen L; Rosenberg G; Wong D; Littlejohn M; Jackson K; Gaggar A; Kitrinos KM; Subramanian GM; Marcellin P; Buti M; Janssen HLA; Gane E; Sozzi V; Colledge D; Hammond R; Edwards R; Locarnini S; Thompson A; Revill PA
    Gut; 2017 Nov; 66(11):2013-2023. PubMed ID: 27534671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of junctional sequences of T cell receptor gamma chain transcripts in gamma delta T cells from rheumatoid synovial fluid.
    Kageyama Y; Koide Y; Miyamoto S; Kushida K; Inoue T; Yoshida TO
    J Rheumatol; 1995 May; 22(5):812-6. PubMed ID: 8587066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.